“…However, in the majority of blood malignancies, it has been noted in less than 10% of patients, depending on the cth detection method (12). Cth has also been observed in very de ned and rare subtypes of ALL, including ETP-ALL, BCP-ALL with internal ampli cation of chromosome 21 (iAMP21), and T-ALL, which develop in the constitutional background of ataxia telangiectasia (8, 13,14). In adult patients with ETP-ALL, somatic mutations and/or deletions of DNA repair/genome stability genes (BLM, STK11, PTEN, ATM, MUTYH, and ATR) have been found, and up to one-third of these cth cases harbored NUP214 rearrangements (14).…”